HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH
Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression
Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression is a funding opportunity from HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, up to 643218, closing March 31, 2027.
Mar 31, 2027
(243d left)Overview
PROJECT SUMMARY The highest priority recommended by NINDS for clinical Parkinson’s research is to define “the features and natural history of prodromal Parkinson disease (PPD), including the events that underlie phenoconversion to clinically manifest PD, and biomarkers or other determinants of prodromal subtypes…